Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Rationalized Development of a Campus-Wide Cell Line Dataset for Implementation in the Biobank LIMS System at Bioresource Center Ghent.

T'Joen V, Vaneeckhaute L, Priem S, Van Woensel S, Bekaert S, Berneel E, Van Der Straeten C.

Front Med (Lausanne). 2019 Jun 25;6:137. doi: 10.3389/fmed.2019.00137. eCollection 2019.

2.

Influence of the ferric uptake regulator (Fur) protein on pathogenicity in Pectobacterium carotovorum subsp. brasiliense.

Tanui CK, Shyntum DY, Priem SL, Theron J, Moleleki LN.

PLoS One. 2017 May 17;12(5):e0177647. doi: 10.1371/journal.pone.0177647. eCollection 2017.

3.

Evaluation of computed tomography in patients with atypical angina or chest pain clinically referred for invasive coronary angiography: randomised controlled trial.

Dewey M, Rief M, Martus P, Kendziora B, Feger S, Dreger H, Priem S, Knebel F, Böhm M, Schlattmann P, Hamm B, Schönenberger E, Laule M, Zimmermann E.

BMJ. 2016 Oct 24;355:i5441. doi: 10.1136/bmj.i5441. Erratum in: BMJ. 2016 Nov 29;355:i6420.

4.

LC-MS/MS quantification of next-generation biotherapeutics: a case study for an IgE binding Nanobody in cynomolgus monkey plasma.

Sandra K, Mortier K, Jorge L, Perez LC, Sandra P, Priem S, Poelmans S, Bouche MP.

Bioanalysis. 2014 May;6(9):1201-13. doi: 10.4155/bio.13.347.

PMID:
24946921
5.

Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura.

Callewaert F, Roodt J, Ulrichts H, Stohr T, van Rensburg WJ, Lamprecht S, Rossenu S, Priem S, Willems W, Holz JB.

Blood. 2012 Oct 25;120(17):3603-10. doi: 10.1182/blood-2012-04-420943. Epub 2012 Sep 4.

PMID:
22948047
6.

Clearance of genotype 1b hepatitis C virus in chimpanzees in the presence of vaccine-induced E1-neutralizing antibodies.

Verstrepen BE, Depla E, Rollier CS, Mares G, Drexhage JA, Priem S, Verschoor EJ, Koopman G, Granier C, Dreux M, Cosset FL, Maertens G, Heeney JL.

J Infect Dis. 2011 Sep 15;204(6):837-44. doi: 10.1093/infdis/jir423.

7.

Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs.

Ulrichts H, Silence K, Schoolmeester A, de Jaegere P, Rossenu S, Roodt J, Priem S, Lauwereys M, Casteels P, Van Bockstaele F, Verschueren K, Stanssens P, Baumeister J, Holz JB.

Blood. 2011 Jul 21;118(3):757-65. doi: 10.1182/blood-2010-11-317859. Epub 2011 May 16.

PMID:
21576702
8.

Isolation and characterization of broadly neutralizing human monoclonal antibodies to the e1 glycoprotein of hepatitis C virus.

Meunier JC, Russell RS, Goossens V, Priem S, Walter H, Depla E, Union A, Faulk KN, Bukh J, Emerson SU, Purcell RH.

J Virol. 2008 Jan;82(2):966-73. Epub 2007 Oct 31.

9.

Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease.

Schröder NW, Diterich I, Zinke A, Eckert J, Draing C, von Baehr V, Hassler D, Priem S, Hahn K, Michelsen KS, Hartung T, Burmester GR, Göbel UB, Hermann C, Schumann RR.

J Immunol. 2005 Aug 15;175(4):2534-40. Erratum in: J Immunol. 2006 May 1;176(9):5682.

10.

[Epidemiology and therapy of Lyme arthritis and other manifestations of Lyme borreliosis in Germany: results of a nation-wide survey].

Priem S, Munkelt K, Franz JK, Schneider U, Werner T, Burmester GR, Krause A.

Z Rheumatol. 2003 Oct;62(5):450-8. German.

PMID:
14579032
11.

Detection of Borrelia burgdorferi DNA in urine of patients with ocular Lyme borreliosis.

Pleyer U, Priem S, Bergmann L, Burmester G, Hartmann C, Krause A.

Br J Ophthalmol. 2001 May;85(5):552-5.

12.

Rapid typing of Borrelia burgdorferi sensu lato species in specimens from patients with different manifestations of Lyme borreliosis.

Lünemann JD, Zarmas S, Priem S, Franz J, Zschenderlein R, Aberer E, Klein R, Schouls L, Burmester GR, Krause A.

J Clin Microbiol. 2001 Mar;39(3):1130-3. Erratum in: J Clin Microbiol 2001 May;39(5):2041.

13.
14.

Improvement of chronic active hepatitis C in chronically infected chimpanzees after therapeutic vaccination with the HCV E1 protein.

Maertens G, Priem S, Ducatteeuw A, Verschoorl E, Verstrepen B, Roskams T, Desmet V, Fuller S, Van Hoek K, Vandeponseele P, Bosman F, Buyse MA, van Doorn LJ, Heeney J, Kos A, Depla E.

Acta Gastroenterol Belg. 2000 Apr-Jun;63(2):203. No abstract available.

PMID:
11023431
15.

Studies on the pathogenesis and treatment of Lyme arthritis.

Franz JK, Priem S, Rittig MG, Burmester GR, Krause A.

Wien Klin Wochenschr. 1999 Dec 10;111(22-23):981-4. Review.

PMID:
10666814
16.

[Etiology and pathogenesis of bacteria-induced arthritis. Infectious arthritis, reactive arthritis, Lyme arthritis].

Priem S, Franz J, Krause A.

Internist (Berl). 1999 Sep;40(9):936-44. Review. German. No abstract available.

PMID:
10506333
17.

[Borrelia PCR: diagnostic Problems Constantly Remain? Why the molecular biology diagnosis cannot replace clinical examination].

Krause A, Priem S, Burmester GR.

Z Rheumatol. 1998 Apr;57(2):79-81. German. No abstract available.

PMID:
9627945
19.

Borrelia burgdorferi induces chemokines in human monocytes.

Sprenger H, Krause A, Kaufmann A, Priem S, Fabian D, Burmester GR, Gemsa D, Rittig MG.

Infect Immun. 1997 Nov;65(11):4384-8.

20.

An optimized PCR leads to rapid and highly sensitive detection of Borrelia burgdorferi in patients with Lyme borreliosis.

Priem S, Rittig MG, Kamradt T, Burmester GR, Krause A.

J Clin Microbiol. 1997 Mar;35(3):685-90.

Supplemental Content

Support Center